Tower Research Capital (TRC)’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,636
| Closed | -$90K | – | 6975 |
|
|
2022
Q2 | $90K | Sell |
1,636
-535
| -25% | -$29.4K | ﹤0.01% | 2382 |
|
|
2022
Q1 | $70K | Buy |
2,171
+866
| +66% | +$27.9K | ﹤0.01% | 2471 |
|
|
2021
Q4 | $28K | Buy |
+1,305
| New | +$28K | ﹤0.01% | 3327 |
|
|
2021
Q2 | – | Sell |
-388
| Closed | -$7K | – | 6157 |
|
|
2021
Q1 | $7K | Sell |
388
-1,514
| -80% | -$27.3K | ﹤0.01% | 4573 |
|
|
2020
Q4 | $30K | Buy |
1,902
+1,521
| +399% | +$24K | ﹤0.01% | 3582 |
|
|
2020
Q3 | $4K | Sell |
381
-5,753
| -94% | -$60.4K | ﹤0.01% | 4465 |
|
|
2020
Q2 | $74K | Buy |
6,134
+5,816
| +1,829% | +$70.2K | ﹤0.01% | 2735 |
|
|
2020
Q1 | $3K | Buy |
+318
| New | +$3K | ﹤0.01% | 2519 |
|
|
2019
Q2 | – | Sell |
-146
| Closed | -$10K | – | 4545 |
|
|
2019
Q1 | $10K | Buy |
+146
| New | +$10K | ﹤0.01% | 2701 |
|
|
2018
Q4 | – | Sell |
-129
| Closed | -$9K | – | 4556 |
|
|
2018
Q3 | $9K | Sell |
129
-99
| -43% | -$6.91K | ﹤0.01% | 2855 |
|
|
2018
Q2 | $27K | Buy |
228
+131
| +135% | +$15.5K | ﹤0.01% | 2250 |
|
|
2018
Q1 | $8K | Buy |
97
+63
| +185% | +$5.2K | ﹤0.01% | 2570 |
|
|
2017
Q4 | $5K | Buy |
+34
| New | +$5K | ﹤0.01% | 2934 |
|
|
2017
Q2 | – | Sell |
-40
| Closed | -$2K | – | 3806 |
|
|
2017
Q1 | $2K | Buy |
+40
| New | +$2K | ﹤0.01% | 2701 |
|
|
2016
Q4 | – | Sell |
-350
| Closed | -$26K | – | 4598 |
|
|
2016
Q3 | $26K | Buy |
350
+306
| +695% | +$22.7K | ﹤0.01% | 1471 |
|
|
2016
Q2 | $4K | Buy |
44
+29
| +193% | +$2.64K | ﹤0.01% | 3584 |
|
|
2016
Q1 | $4K | Buy |
15
+10
| +200% | +$2.67K | ﹤0.01% | 2962 |
|
|
2015
Q4 | $3K | Sell |
5
-50
| -91% | -$30K | ﹤0.01% | 3563 |
|
|
2015
Q3 | $45K | Buy |
+55
| New | +$45K | ﹤0.01% | 1102 |
|